参考文献
[1]
BrayF, FerlayJ, SoerjomataramI, et al.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].
CA Cancer J Clin,
2018,
68(
6):
394-
424.
.
[2]
郑荣寿，孙可欣，张思维，等.
2015年中国恶性肿瘤流行情况分析[J].
中华肿瘤杂志，
2019,
41(
1)：
19-
28.
.
ZhengRS, SunKX, ZhangSW, et al.
Analysis of the prevalence of malignant tumors in China in 2015[J].
Chin J Oncol,
2019,
41(
1):
19-
28.
.
[3]
DeSantisCE, MaJ, GaudetMM, et al.
Breast cancer statistics, 2019[J].
CA Cancer J Clin,
2019,
69(
6):
438-
451.
.
[4]
ChenW, ZhengR, BaadePD, et al.
Cancer statistics in China, 2015[J].
Cancer J Clin,
2016,
66(
2):
115-
132.
.
[5]
陈万青，李霓，石菊芳，等.
中国城市癌症早诊早治项目进展[J].
中国肿瘤，
2019,
28(
1)：
23-
25.
.
ChenWQ, LiN, ShiJF, et al.
Progress in early diagnosis and early treatment of urban cancer in China[J].
China Cancer,
2019,
28(
1):
23-
25.
.
[6]
黄静，杨湘红，刘爱，等.
农村地区妇女"两癌筛查"项目实施中的问题与对策[J].
中国全科医学，
2020,
23(
13)：
1680-
1686.
.
HuangJ, YangXH, LiuA, et al.
Problems and countermeasures in the implementation of national cervical and breast screening program for women in rural areas[J].
Chin Gen Prac,
2020,
23(
13):
1680-
1686.
.
[7]
BeversTB, HelvieM, BonaccioE, et al.
Breast cancer screening and diagnosis, Version 3.2018, NCCN clinical practice guidelines in oncology[J].
J Natl Compr Canc Netw,
2018,
16(
11):
1362-
1389.
.
[8]
KlarenbachS, Sims-JonesN, LewinG, et al.
Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer[J].
CMAJ,
2018,
190(
49):
E1441-
E1451.
.
[9]
QaseemA, SnowV, SherifK, et al.
Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American college of physicians[J].
Ann Intern Med,
2007,
146(
7):
511-
515.
.
[10]
SiuAL, U. S. Preventive Services Task Force.
Screening for breast cancer: U. S. Preventive Services Task Force recommendation statement[J].
Ann Intern Med,
2016,
164(
4):
279-
296.
.
[11]
中国抗癌协会乳腺癌专业委员会.
中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J].
中国癌症杂志，
2019,
29(
8)：
609-
679.
.
China Cancer Society Breast Cancer Committee.
Guidelines for the diagnosis and treatment of breast cancer in China Anticancer Association(2019 Edition)[J].
Chin Oncol,
2019,
29(
8):
609-
679.
.
[12]
中国抗癌协会，国家肿瘤临床医学研究中心(天津医科大学肿瘤医院).
中国女性乳腺癌筛查指南[J].
中国肿瘤临床，
2019,
46(
9)：
430-
431.
.
China Anti-cancer Association, National Clinical Research Center for Cancer(Tianjin Medical University Cancer Institute & Hospital).
China guideline for the screening of breast cancer[J].
Chin J Clin Oncol,
2019,
46(
9):
430-
431.
.
[13]
GrilliR, MagriniN, PennaA, et al.
Practice guidelines developed by specialty societies: the need for a critical appraisal[J].
Lancet,
2000,
355(
9198):
103-
106.
.
[14]
陈耀龙，王小琴，王琪，等.
遵循指南报告规范提升指南报告质量[J].
中华内科杂志，
2018,
57(
3)：
168-
170.
.
ChenYL, WangXQ, WangQ, et al.
Follow the guidelines to report on the quality of the improved guidelines report[J].
Chin J Intern Med,
2018,
57(
3):
168-
170.
.
[15]
蒋朱明，詹思延，贾晓巍，等.
制订/修订《临床诊疗指南》的基本方法及程序[J].
中华医学杂志，
2016,
96(
4)：
250-
253.
.
JiangZM, ZhanSY, JiaXW, et al.
Basic methods and procedures for the development/revision of the clinical guidelines[J].
Natl Med J China,
2016,
96(
4):
250-
253.
.
[16]
VernooijRW, Alonso-CoelloP, BrouwersM, et al.
Reporting items for updated clinical guidelines: checklist for the reporting of updated guidelines (CheckUp)[J].
PLoS Med,
2017,
14(
1):
e1002207.
.
[17]
BrouwersMC, KhoME, BrowmanGP, et al.
AGREE Ⅱ: advancing guideline development, reporting and evaluation in health care[J].
J Clin Epidemiol,
2010,
63(
12):
1308-
1311.
.
[18]
ChenY, YangK, MarušicA, et al.
A reporting tool for practice guidelines in health care: the RIGHT statement[J].
Ann Intern Med,
2017,
166(
2):
128-
132.
.
[19]
PollockM, FernandesRM, HartlingL.
Evaluation of AMSTAR to assess the methodological quality of systematic reviews in overviews of reviews of healthcare interventions[J].
BMC Med Res Methodol,
2017,
17(
1):
48.
.
[20]
SheaBJ, GrimshawJM, WellsGA, et al.
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews[J].
BMC Med Res Methodol,
2007,
7:
10.
.
[21]
HigginsJP, AltmanDG, GøtzschePC, et al.
The cochrane collaboration′s tool for assessing risk of bias in randomised trials[J].
BMJ,
2011,
343:
d5928.
.
[22]
WhitingPF, RutjesAW, WestwoodME, et al.
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies[J].
Ann Intern Med,
2011,
155(
8):
529-
536.
.
[23]
WellsG.
The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses[C].
Symposium on Systematic Reviews: Beyond the Basics.
2014.
[24]
陈耀龙，姚亮，NorrisS, 等.
GRADE在系统评价中应用的必要性及注意事项[J].
中国循证医学杂志，
2013,
13(
12)：
1401-
1404.
.
ChenYL, YaoL, NorrisS, et al.
Application of GRADE in systematic reviews: necessity, frequently-asked questions and concerns[J].
Chin J Evid-Based Med,
2013,
13(
12):
1401-
1404.
.
[25]
GuyattGH, OxmanAD, VistGE, et al.
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations[J].
BMJ,
2008,
336(
7650):
924-
926.
.
[26]
BrożekJL, AklEA, CompalatiE, et al.
Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations[J].
Allergy,
2011,
66(
5):
588-
595.
.
[27]
FerlayJEM, Lamf, ColombetM, et al.
Global Cancer Observatory: Cancer Today. [EB/OL]. [
2021-02-26].
https://gco.iarc.fr/today.
[28]
孙可欣，郑荣寿，张思维，等.
2015年中国分地区恶性肿瘤发病和死亡分析[J].
中国肿瘤，
2019,
28(
1)：
1-
11.
.
SunKX, ZhengRS, ZhangSW, et al.
Report of cancer incidence and mortality in different areas of China, 2015[J].
China Cancer,
2019,
28(
1):
1-
11.
.
[29]
张敏璐，彭鹏，吴春晓，等.
2008—2012年中国肿瘤登记地区女性乳腺癌发病和死亡分析[J].
中华肿瘤杂志，
2019,
41(
4)：
315-
320.
.
ZhangML, PengP, WuCX, et al.
Report of breast cancer incidence and mortality in China registry regions, 2008-2012[J].
Chin J Oncol,
2019,
41(
4):
315-
320.
.
[30]
孙可欣，郑荣寿，顾秀瑛，等.
2000—2014年中国肿瘤登记地区女性乳腺癌发病趋势及年龄变化情况分析[J].
中华预防医学杂志，
2018,
52(
6)：
567-
572.
.
SunKX, ZhengRS, GuXY, et al.
Analysis of the incidence trend and age of female breast cancer in China′s cancer register area from 2000 to 2014[J].
Chin J Prev Med,
2018,
52(
6):
567-
572.
.
[31]
HuangZ, WenW, ZhengY, et al.
Breast cancer incidence and mortality: trends over 40 years among women in Shanghai, China[J].
Ann Oncol,
2016,
27(
6):
1129-
1134.
.
[32]
FanL, Strasser-WeipplK, LiJJ, et al.
Breast cancer in China[J].
Lancet Oncol,
2014,
15(
7):
e279-
e289.
.
[33]
李贺，郑荣寿，张思维，等.
2014年中国女性乳腺癌发病与死亡分析[J].
中华肿瘤杂志，
2018,
40(
3)：
166-
171.
.
LiH, ZhengRS, ZhangSW, et al.
Incidence and mortality of female breast cancer in China, 2014[J].
Chin J Oncol,
2018,
40(
3):
166-
171.
.
[34]
ZengH, ChenW, ZhengR, et al.
Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries[J].
Lancet Glob Health,
2018,
6(
5):
e555-
e567.
.
[35]
李红，李朋，陈震.
乳腺癌发病危险因素的Meta分析[J].
实用预防医学，
2014,
21(
9)：
1097-
1101.
.
LiH, LiP, ChenZ.
Meta analysis of risk factors for incidence of breast cancer[J].
J Pract Prev Med,
2014,
21(
9):
1097-
1101.
.
[36]
戴琼，杜玉开.
女性乳腺癌危险因素的Meta分析[J].
中华疾病控制杂志，
2010,
14(
6)：
544-
547.
DaiQ, DuYK.
Meta analysis of risk factors for breast cancer in women[J].
Chin J Disease Control & Prev,
2010,
14(
6):
544-
547.
[37]
裴广军，付莉，崔亚玲，等.
中国女性乳腺癌危险因素的Meta分析[J].
中国妇幼保健，
2008,
23(
19)：
2650-
2652.
.
PeiGJ, FuL, CuiYL, et al.
Meta-analysis on the risk factors of breast cancer among Chinese female[J].
Maternal and Child Health Care of China,
2008,
23(
19):
2650-
2652.
.
[38]
KvaskoffM, Mahamat-SalehY, FarlandLV, et al.
Endometriosis and cancer: a systematic review and meta-analysis[J].
Hum Reprod Update,
2020,
17:
dmaa045.
.
[39]
KeyTJ, ApplebyPN, ReevesGK, et al.
Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: reanalysis of eighteen prospective studies[J].
Steroids,
2015,
99(
Pt A):
49-
55.
.
[40]
FarhatGN, CummingsSR, ChlebowskiRT, et al.
Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers[J].
J Natl Cancer Inst,
2011,
103(
7):
562-
570.
.
[41]
Endogenous Hormones and Breast Cancer Collaborative Group, KeyTJ, ApplebyPN.
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies[J].
Lancet Oncol,
2013,
14(
10):
1009-
1019.
.
[42]
RitteR, LukanovaA, TjønnelandA, et al.
Height, age at menarche and risk of hormone receptor-positive and-negative breast cancer: a cohort study[J].
Int J Cancer,
2013,
132(
11):
2619-
2629.
.
[43]
CuiY, Deming-HalversonSL, ShrubsoleMJ, et al.
Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women[J].
Clin Breast Cancer,
2014,
14(
6):
417-
425.
.
[44]
Collaborative Group on Hormonal Factors in Breast Cancer.
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies[J].
Lancet Oncol,
2012,
13(
11):
1141-
1151.
.
[45]
Collaborative Group on Hormonal Factors in Breast Cancer.
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52, 705 women with breast cancer and 108, 411 women without breast cancer[J].
Lancet,
1997,
350(
9084):
1047-
1059.
[46]
HuangY, ZhangX, LiW, et al.
A meta-analysis of the association between induced abortion and breast cancer risk among Chinese females[J].
Cancer Causes Control,
2014,
25(
2):
227-
236.
.
[47]
NindreaRD, AryandonoT, LazuardiL, et al.
Family history of breast cancer and breast cancer risk between malays ethnicity in Malaysia and Indonesia: a meta-analysis[J].
Iran J Public Health,
2019,
48(
2):
198-
205.
[48]
VishwakarmaG, NdetanH, DasDN, et al.
Reproductive factors and breast cancer risk: a meta-analysis of case-control studies in Indian women[J].
South Asian J Cancer,
2019,
8(
2):
80-
84.
.
[49]
AntoniouA, PharoahPD, NarodS, et al.
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies[J].
Am J Hum Genet,
2003,
72(
5):
1117-
1130.
.
[50]
ChenS, ParmigianiG.
Meta-analysis of BRCA1 and BRCA2 penetrance[J].
J Clin Oncol,
2007,
25(
11):
1329-
1133.
.
[51]
MavaddatN, PeockS, FrostD, et al.
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE[J].
J Natl Cancer Inst,
2013,
105(
11):
812-
822.
.
[52]
KuchenbaeckerKB, HopperJL, BarnesDR, et al.
Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers[J].
JAMA,
2017,
317(
23):
2402-
2416.
.
[53]
CopsonER, MaishmanTC, TapperWJ, et al.
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study[J].
Lancet Oncol,
2018,
19(
2):
169-
180.
.
[54]
TunNM, VillaniG, OngK, et al.
Risk of having BRCA1 mutation in high-risk women with triple-negative breast cancer: a meta-analysis[J].
Clin Genet,
2014,
85(
1):
43-
48.
.
[55]
GuoT, RenY, WangB, et al.
Promoter methylation of BRCA1 is associated with estrogen, progesterone and human epidermal growth factor receptor-negative tumors and the prognosis of breast cancer: a meta-analysis[J].
Mol Clin Oncol,
2015,
3(
6):
1353-
1360.
.
[56]
NamaziN, IrandoostP, HeshmatiJ, et al.
The association between fat mass and the risk of breast cancer: a systematic review and meta-analysis[J].
Clin Nutr,
2019,
38(
4):
1496-
1503.
.
[57]
World Cancer Research Fund/American Institute for Cancer Research.
Diet, nutrition, physical activity and cancer: a global perspective. Continuous update project expert report 2018[EB/OL]. [
2020-11-10].
http:dietandcancerreport.org.
[58]
BagnardiV, RotaM, BotteriE, et al.
Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis[J].
Br J Cancer,
2015,
112(
3):
580-
593.
.
[59]
BagnardiV, RotaM, BotteriE, et al.
Light alcohol drinking and cancer: a meta-analysis[J].
Ann Oncol,
2013,
24(
2):
301-
308.
.
[60]
KeyJ, HodgsonS, OmarRZ, et al.
Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues[J].
Cancer Causes Control,
2006,
17(
6):
759-
770.
.
[61]
ChoiYJ, MyungSK, LeeJH.
Light alcohol drinking and risk of cancer: a meta-analysis of cohort studies[J].
Cancer Res Treat,
2018,
50(
2):
474-
487.
.
[62]
GramIT, ParkSY, KolonelLN, et al.
Smoking and risk of breast cancer in a racially/ethnically diverse population of mainly women who do not drink alcohol: the MEC study[J].
Am J Epidemiol,
2015,
182(
11):
917-
925.
.
[63]
陶苹，胡耀月，黄源，等.
亚裔女性乳腺癌危险因素的Meta分析[J].
中华流行病学杂志，
2011,
32(
2)：
164-
169.
.
TaoP, HuYY, HuangY, et al.
Meta analysis of breast cancer risk factors in Asian women[J].
Chin J Epidemiol,
32(
2):
164-
169.
.
[64]
National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health.
The health consequences of smoking—50 years of progress: a report of the surgeon general[M].
Atlanta (GA):
Centers for Disease Control and Prevention (US),
2014.
[65]
GaudetMM, GapsturSM, SunJ, et al.
Active smoking and breast cancer risk: original cohort data and meta-analysis[J].
J Natl Cancer Inst,
2013,
105(
8):
515-
525.
.
[66]
GaudetMM, CarterBD, BrintonLA, et al.
Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies[J].
I Int J Epidemiol,
2017,
46(
3):
881-
893.
.
[67]
RonE.
Cancer risks from medical radiation[J].
Health Phys,
2003,
85(
1):
47-
59.
.
[68]
KooE, HendersonMA, DwyerM, et al.
Management and prevention of breast cancer after radiation to the chest for childhood, adolescent, and young adulthood malignancy[J].
Ann Surg Oncol,
2015,
22(
Suppl 3):
S545-
S551.
.
[69]
MoskowitzCS, ChouJF, WoldenSL, et al.
Breast cancer after chest radiation therapy for childhood cancer[J].
J Clin Oncol,
2014,
32(
21):
2217-
2223.
.
[70]
ChowdhuryR, SinhaB, SankarMJ, et al.
Breastfeeding and maternal health outcomes: a systematic review and meta-analysis[J].
Acta Paediatr,
2015,
104(
467):
96-
113.
.
[71]
VictoraCG, BahlR, BarrosAJ, et al.
Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect[J].
Lancet,
2016,
387(
10017):
475-
490.
.
[72]
ShamshirianA, HeydariK, ShamsZ, et al.
Breast cancer risk factors in Iran: a systematic review & meta-analysis[J].
Horm Mol Biol Clin Investig,
2020,
20:
.
.
[73]
ZhouY, ChenJ, LiQ, et al.
Association between breastfeeding and breast cancer risk: evidence from a meta-analysis[J].
Breastfeed Med,
2015,
10(
3):
175-
182.
.
[74]
McTiernanA, KooperbergC, WhiteE, et al.
Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women′s Health Initiative Cohort Study[J].
JAMA,
2003,
290(
10):
1331-
1336.
.
[75]
PizotC, BoniolM, MullieP, et al.
Physical activity, hormone replacement therapy and breast cancer risk: a meta-analysis of prospective studies[J].
Eur J Cancer,
2016,
52:
138-
154.
.
[76]
WHO Classification of Tumors Editorial Board.
WHO classification of tumours series, breast tumors. 5th ed[M].
Lyon (France):
International Agency for Research on Cancer,
2019.
[77]
MahulBA, EdgeSB, GreeneFL, et al.
AJCC Cancer Staging Manual 8th ed[M].
New York:
Springer,
2017.
[80]
YenAM, DuffySW, ChenTH, et al.
Long-term incidence of breast cancer by trial arm in one county of the Swedish two-county trial of mammographic screening[J].
Cancer,
2012,
118(
23):
5728-
5732.
.
[81]
EtzioniR, GulatiR, Mallinger, et al.
Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening[J].
Ann Intern Med,
2013,
158(
11):
831-
838.
.
[82]
ChristiansenCL, WangF, BartonMB, et al.
Predicting the cumulative risk of false-positive mammograms[J].
J Natl Cancer Inst,
2000,
92(
20):
1657-
1666.
.
[83]
BrewerNT, SalzT, LillieSE.
Systematic review: the long-term effects of false-positive mammograms[J].
Ann Intern Med,
2007,
146(
7):
502-
510.
.
[84]
KerlikowskeK, GradyD, BarclayJ, et al.
Positive predictive value of screening mammography by age and family history of breast cancer[J].
JAMA,
1993,
270(
20):
2444-
2450.
.
[85]
MandelblattJS, CroninKA, BaileyS, et al.
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms[J].
Ann Intern Med,
2009,
151(
10):
738-
747.
.
[86]
BartonMB, MooreS, PolkS, et al.
Increased patient concern after false-positive mammograms: clinician documentation and subsequent ambulatory visits[J].
J Gen Intern Med,
2001,
16(
3):
150-
156.
.
[88]
MillerD, LivingstoneV, HerbisonP.
Interventions for relieving the pain and discomfort of screening mammography[J].
Cochrane Database Syst Rev,
2008, (
1):
CD002942.
.
[89]
LambertzCK, JohnsonCJ, MontgomeryPG, et al.
Premedication to reduce discomfort during screening mammography[J].
Radiology,
2008,
248(
3):
765-
772.
.
[90]
PetticrewMP, SowdenAJ, Lister-SharpD, et al.
False-negative results in screening programmes: systematic review of impact and implications[J].
Health Technol Assess,
2000,
4(
5):
1-
120.
[91]
IARC Working Group on the Evaluation of Cancer-Preventive Interventions.
Breast cancer screening[M].
Lyon (FR):
International Agency for Research on Cancer,
2016.
[92]
National Institute for Health and Care Excellence(NICE) (2019).
Familial breast cancer classification, care and managing breast cancer and related risks in people with a family history of breast cancer[EB/OL]. [
2020-12-27].
https://www.nice.org.uk/guidance/cg164.
[93]
MonticcioloDL, NewellMS, MoyL, et al.
Breast cancer screening in women at higher-than-average risk: recommendations from the ACR[J].
J Am Coll Radiol,
2018,
15(
3
Pt A):
408-
414.
.
[94]
SauvenP.
Guidelines for the management of women at increased familial risk of breast cancer[J].
Eur J Cancer,
2004,
40(
5):
653-
665.
.
[95]
MoyerVA, U. S. Preventive Services Task Force.
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U. S. Preventive Services Task Force recommendation statement[J].
Ann Intern Med,
2014,
160(
4):
271-
281.
.
[96]
NelsonHD, PappasM, ZakherB, et al.
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U. S. Preventive Services Task Force recommendation[J].
Ann Intern Med,
2014,
160(
4):
255-
266.
.
[97]
GilpinCA, CarsonN, HunterAG.
A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center[J].
Clin Genet,
2000,
58(
4):
299-
308.
.
[98]
EvansDG, EcclesDM, RahmanN, et al.
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO[J].
J Med Genet,
2004,
41(
6):
474-
480.
.
[99]
BellcrossCA, LemkeAA, PapeLS, et al.
Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population[J].
Genet Med,
2009,
11(
11):
783-
789.
.
[100]
HoskinsKF, ZwaagstraA, RanzM.
Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening[J].
Cancer,
2006,
107(
8):
1769-
1776.
.
[101]
Ashton-ProllaP, GiacomazziJ, SchmidtAV, et al.
Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care[J].
BMC cancer,
2009,
9:
283.
.
[102]
OeffingerKC, FonthamET, EtzioniR, et al.
Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society[J].
JAMA,
2015,
314(
15):
1599-
1614.
.
[103]
QaseemA, LinJS, MustafaRA, et al.
Screening for breast cancer in average-risk women: A guidance statement from the american college of physicians[J].
Ann Intern Med,
2019,
170(
8):
547-
560.
.
[104]
HaddenWE.
Recommendations for the surveillance of young women at increased risk for breast cancer[J].
Australas Radiol,
2007,
51(
1):
1-
11.
.
[105]
GaroutR, AhmedH, JastaniahS, et al.
Magnetic resonance imaging for screening of woman at high-risk of breast cancer[J].
Adv Breast Cancer Res,
2018,
3(
3):
59-
67.
[106]
LeungGM, ThachTQ, LamTH, et al.
Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis[J].
Br J Cancer,
2002,
87(
9):
982-
988.
.
[107]
MinamiY, TsubonoY, NishinoY, et al.
The increase of female breast cancer incidence in Japan: emergence of birth cohort effect[J].
Int J Cancer,
2004,
108(
6):
901-
906.
.
[108]
AlexanderFE, AndersonTJ, BrownHK, et al.
14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening[J].
Lancet,
1999,
353(
9168):
1903-
1908.
.
[109]
BjurstamN, BjörneldL, WarwickJ, et al.
The gothenburg breast screening trial[J].
Cancer,
2003,
97(
10):
2387-
2396.
.
[110]
FrisellJ, LidbrinkE, HellströmL, et al.
Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial[J].
Breast Cancer Res Treat,
1997,
45(
3):
263-
270.
.
[111]
HabbemaJD, van OortmarssenGJ, van PuttenDJ, et al.
Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the health insurance plan of greater New York study[J].
J Natl Cancer Inst,
1986,
77(
2):
317-
320.
[112]
MillerAB, WallC, BainesCJ, et al.
Twenty five year follow-up for breast cancer incidence and mortality of the Canadian national breast screening study: randomised screening trial[J].
BMJ,
2014,
348:
g366.
.
[113]
MossSM, WaleC, SmithR, et al.
Effect of mammographic screening from age 40 years on breast cancer mortality in the UK age trial at 17 years′ follow-up: a randomised controlled trial[J].
Lancet Oncol,
2015,
16(
9):
1123-
1132.
.
[114]
NyströmL, AnderssonI, BjurstamN, et al.
Long-term effects of mammography screening: updated overview of the Swedish randomised trials[J].
Lancet,
2002,
359(
9310):
909-
919.
.
[115]
TabarL, FagerbergG, ChenHH, et al.
Efficacy of breast cancer screening by age. New results from the Swedish two-county trial[J].
Cancer,
1995,
75(
10):
2507-
2517.
.
[116]
BraithwaiteD, ZhuW, HubbardRA, et al.
Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates？[J].
J Natl Cancer Inst,
2013,
105(
5):
334-
341.
.
[117]
ColdmanAJ, PhillipsN, OlivottoIA, et al.
Impact of changing from annual to biennial mammographic screening on breast cancer outcomes in women aged 50-79 in British Columbia[J].
J Med Screen,
2008,
15(
4):
182-
187.
.
[118]
DittusK, GellerB, WeaverDL, et al.
Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI[J].
J Gen Intern Med,
2013,
28(
11):
1454-
1462.
.
[119]
GoelA, LittenbergB, BurackRC.
The association between the pre-diagnosis mammography screening interval and advanced breast cancer[J].
Breast Cancer Res Treat,
2007,
102(
3):
339-
345.
.
[120]
Breast Screening Frequency Trial Group.
The frequency of breast cancer screening: results from the UKCCCR randomised trial. United Kingdom Co-ordinating Committee on cancer research[J].
Eur J Cancer,
2002,
38(
11):
1458-
1464.
.
[121]
HubbardRA, KerlikowskeK, FlowersCI, et al.
Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study[J].
Ann Intern Med,
2011,
155(
8):
481-
492.
.
[122]
KerlikowskeK, ZhuW, HubbardRA, et al.
Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy[J].
JAMA Intern Med,
2013,
173(
9):
807-
816.
.
[123]
MigliorettiDL, ZhuW, KerlikowskeK, et al.
Breast tumor prognostic characteristics and biennial vs annual mammography, age, and menopausal status[J].
JAMA oncology,
2015,
1(
8):
1069-
1077.
.
[124]
O′MearaES, ZhuW, HubbardRA, et al.
Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age[J].
Cancer,
2013,
119(
22):
3959-
3967.
.
[125]
ParvinenI, ChiuS, PylkkänenL, et al.
Effects of annual vs triennial mammography interval on breast cancer incidence and mortality in ages 40-49 in Finland[J].
Br J Cancer,
2011,
105(
9):
1388-
1391.
.
[126]
SimonMS, Wassertheil-SmollerS, ThomsonCA, et al.
Mammography interval and breast cancer mortality in women over the age of 75[J].
Breast Cancer Res Treat,
2014,
148(
1):
187-
195.
.
[127]
WhiteE, MigliorettiDL, YankaskasBC, et al.
Biennial versus annual mammography and the risk of late-stage breast cancer[J].
J Natl Cancer Inst,
2004,
96(
24):
1832-
1839.
.
[128]
WinchCJ, ShermanKA, BoyagesJ.
Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50[J].
Breast Cancer Res Treat,
2015,
149(
1):
211-
221.
.
[129]
AhmadinejadN, MovahediniaS, MovahediniaS, et al.
Association of mammographic density with pathologic findings[J].
Iran Red Crescent Med J,
2013,
15(
12):
e16698.
.
[130]
AlsheikNH, DabbousF, PohlmanSK, et al.
Comparison of resource utilization and clinical outcomes following screening with digital breast tomosynthesis versus digital mammography: findings from a learning health system[J].
Acad Radiol,
2019,
26(
5):
597-
605.
.
[131]
AnderssonI.
Radiographic screening for breast carcinoma. Ⅰ. program and primary findings in 45-69 year old women[J].
Acta Radiol Diagn,
1981,
22(
2):
185-
194.
.
[132]
BadanGM, Roveda JúniorD, FerreiraCA, et al.
Complete internal audit of a mammography service in a reference institution for breast imaging[J].
Radiol Bras,
2014,
47(
2):
74-
78.
.
[133]
BainesC, MillerA, WallC, et al.
Sensitivity and specificity of first screen mammography in the Canadian National Breast Screening Study: a preliminary report from five centers[J].
Radiology,
1986,
160(
2):
295-
298.
.
[134]
BihrmannK, JensenA, OlsenAH, et al.
Performance of systematic and non-systematic ('opportunistic’) screening mammography: a comparative study from Denmark[J].
J Med Screen,
2008,
15(
1):
23-
26.
.
[135]
BulliardJL, De LandtsheerJP, LeviF.
Results from the Swiss mammography screening pilot programme[J].
Eur J Cancer,
2003,
39(
12):
1761-
1769.
.
[136]
CampariC, Giorgi RossiP, MoriCA, et al.
Impact of the introduction of digital mammography in an organized screening program on the recall and detection rate[J].
J Digit Imaging,
2016,
29(
2):
235-
242.
.
[137]
CheungYC, LinYC, WanYL, et al.
Diagnostic performance of dual-energy contrast-enhanced subtracted mammography in dense breasts compared to mammography alone: interobserver blind-reading analysis[J].
Eur Radiol,
2014,
24(
10):
2394-
2403.
.
[138]
ConantEF, BarlowWE, HerschornSD, et al.
Association of digital breast tomosynthesis vs digital mammography with cancer detection and recall rates by age and breast density[J].
JAMA Oncol,
2019,
5(
5):
635-
642.
.
[139]
ConantEF, BeaberEF, SpragueBL, et al.
Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium[J].
Breast Cancer Res Treat,
2016,
156(
1):
109-
116.
.
[140]
DabbousF, DolecekTA, FriedewaldSM, et al.
Performance characteristics of digital vs film screen mammography in community practice[J].
Breast J,
2018,
24(
3):
369-
372.
.
[141]
DibbleEH, LourencoAP, BairdGL, et al.
Comparison of digital mammography and digital breast tomosynthesis in the detection of architectural distortion[J].
Eur Radiol,
2018,
28(
1):
3-
10.
.
[142]
ŁuczyńskaE, NiemiecJ, HendrickE, et al.
Degree of enhancement on contrast enhanced spectral mammography (CESM) and lesion type on mammography (MG): comparison based on histological results[J].
Med Sci Monit,
2016,
22：
3886-
3893.
.
[143]
Euler-ChelpinM, LillholmM, NapolitanoG, et al.
Screening mammography: benefit of double reading by breast density[J].
Breast Cancer Res Treat,
2018,
171(
3):
767-
776.
.
[144]
GeertseTD, HollandR, TimmersJM, et al.
Value of audits in breast cancer screening quality assurance programmes[J].
Eur Radiol,
2015,
25(
11):
3338-
3347.
.
[145]
GillKS, YankaskasBC.
Screening mammography performance and cancer detection among black women and white women in community practice[J].
Cancer,
2004,
100(
1):
139-
148.
.
[146]
HeinzenMT, YankaskasBC, KwokRK.
Comparison of woman-specific versus breast-specific data for reporting screening mammography performance[J].
Acad Radiol,
2000,
7(
4):
232-
236.
.
[147]
HendersonLM, O′MearaES, BraithwaiteD, et al.
Performance of digital screening mammography among older women in the United States[J].
Cancer,
2015,
121(
9):
1379-
1386.
.
[148]
HongS, SongSY, ParkB, et al.
Effect of digital mammography for breast cancer screening: a comparative study of more than 8 million Korean women[J].
Radiology,
2020,
294(
2):
247-
255.
.
[149]
HonjoS, AndoJ, TsukiokaT, et al.
Relative and combined performance of mammography and ultrasonography for breast cancer screening in the general population: a pilot study in tochigi prefecture, Japan[J].
Jpn J Clin Oncol,
2007,
37(
9):
715-
720.
.
[150]
HoussamiN, AbrahamLA, MigliorettiDL, et al.
Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer[J].
JAMA,
2011,
305(
8):
790-
799.
.
[151]
HoussamiN, AbrahamLA, OnegaT, et al.
Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast[J].
Breast Cancer Res Treat,
2014,
145(
3):
765-
773.
.
[152]
HovdaT, HolenÅS, LångK, et al.
Interval and consecutive round breast cancer after digital breast tomosynthesis and synthetic 2D mammography versus standard 2D digital mammography in breastscreen Norway[J].
Radiology,
2020,
294(
2):
256-
264.
.
[153]
HuangY, KangM, LiH, et al.
Combined performance of physical examination, mammography, and ultrasonography for breast cancer screening among Chinese women: a follow-up study[J].
Curr Oncol,
2012,
19(
Suppl 2):
eS22-
eS30.
.
[154]
KavanaghAM, GilesGG, MitchellH, et al.
The sensitivity, specificity, and positive predictive value of screening mammography and symptomatic status[J].
J Med Screen,
2000,
7(
2):
105-
110.
.
[155]
Kemp JacobsenK, O′MearaES, KeyD, et al.
Comparing sensitivity and specificity of screening mammography in the United States and Denmark[J].
Int J Cancer,
2015,
137(
9):
2198-
2207.
.
[156]
KerlikowskeK, CarneyPA, GellerB, et al.
Performance of screening mammography among women with and without a first-degree relative with breast cancer[J].
Ann Intern Med,
2000,
133(
11):
855-
863.
.
[157]
KerlikowskeK, CreasmanJ, LeungJW, et al.
Differences in screening mammography outcomes among white, Chinese, and Filipino women[J].
Arch Intern Med,
2005,
165(
16):
1862-
1868.
.
[158]
KwongA, CheungPS, WongAY, et al.
The acceptance and feasibility of breast cancer screening in the East[J].
Breast,
2008,
17(
1):
42-
50.
.
[159]
LeeEH, KimKW, KimYJ, et al.
Performance of screening mammography: a report of the alliance for breast cancer screening in Korea[J].
Korean J Radiol,
2016,
17(
4):
489-
496.
.
[160]
LeeJM, AraoRF, SpragueBL, et al.
Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk[J].
JAMA Intern Med,
2019,
179(
5):
658-
667.
.
[161]
LewinJM, HendrickRE, D′OrsiCJ, et al.
Comparison of full-field digital mammography with screen-film mammography for cancer detection: results of 4, 945 paired examinations[J].
Radiology,
2001,
218(
3):
873-
880.
.
[162]
McDowellG, LuntLG, McLeanL, et al.
The sensitivity of the assessment process in screening mammography[J].
Breast,
2002,
11(
2):
120-
124.
.
[163]
MigliorettiDL, WalkerR, WeaverDL, et al.
Accuracy of screening mammography varies by week of menstrual cycle[J].
Radiology,
2011,
258(
2):
372-
379.
.
[164]
NormanSA, LocalioAR, ZhouL, et al.
Validation of self-reported screening mammography histories among women with and without breast cancer[J].
Am J Epidemiol,
2003,
158(
3):
264-
271.
.
[165]
OhuchiN, SuzukiA, SobueT, et al.
Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan strategic anti-cancer randomized trial (J-START): a randomised controlled trial[J].
Lancet,
2016,
387(
10016):
341-
348.
.
[166]
OmidijiOA, CampbellPC, IrurheNK, et al.
Breast cancer screening in a resource poor country: ultrasound versus mammography[J].
Ghana Med J,
2017,
51(
1):
6-
12.
.
[167]
PisanoED, GatsonisC, HendrickE, et al.
Diagnostic performance of digital versus film mammography for breast-cancer screening[J].
N Engl J Med,
2005,
353(
17):
1773-
1783.
.
[168]
PisanoED, HendrickRE, YaffeMJ, et al.
Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST[J].
Radiology,
2008,
246(
2):
376-
383.
.
[169]
PoplackSP, TostesonAN, GroveMR, et al.
Mammography in 53, 803 women from the New Hampshire mammography network[J].
Radiology,
2000,
217(
3):
832-
840.
.
[170]
PrummelMV, MuradaliD, ShumakR, et al.
Digital compared with screen-film mammography: measures of diagnostic accuracy among women screened in the Ontario breast screening program[J].
Radiology,
2016,
278(
2):
365-
373.
.
[171]
Rodriguez-RuizA, Gubern-MeridaA, Imhof-TasM, et al.
One-view digital breast tomosynthesis as a stand-alone modality for breast cancer detection: do we need more？[J].
Eur Radiol,
2018,
28(
5):
1938-
1948.
.
[172]
RosenbergRD, LandoJF, HuntWC, et al.
The New Mexico mammography project. Screening mammography performance in Albuquerque, New Mexico, 1991 to 1993[J].
Cancer,
1996,
78(
8):
1731-
1739.
.
[173]
SalaM, DomingoL, MaciàF, et al.
Does digital mammography suppose an advance in early diagnosis? Trends in performance indicators 6 years after digitalization[J].
Eur Radiol,
2015,
25(
3):
850-
859.
.
[174]
SankatsingVDV, FracheboudJ, de MunckL, et al.
Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening[J].
BMC cancer,
2018,
18(
1):
256.
.
[175]
SienkoDG, HahnRA, MillsEM, et al.
Mammography use and outcomes in a community. The greater lansing area mammography study[J].
Cancer,
1993,
71(
5):
1801-
1809.
.
[176]
SinclairN, LittenbergB, GellerB, et al.
Accuracy of screening mammography in older women[J].
AJR Am J Roentgenol,
2011,
197(
5):
1268-
1273.
.
[177]
SkaaneP, BandosAI, NiklasonLT, et al.
Digital mammography versus digital mammography plus tomosynthesis in breast cancer screening: The Oslo tomosynthesis screening trial[J].
Radiology,
2019,
291(
1):
23-
30.
.
[178]
SkaaneP, HofvindS, SkjennaldA.
Randomized trial of screen-film versus full-field digital mammography with soft-copy reading in population-based screening program: follow-up and final results of Oslo Ⅱ study[J].
Radiology,
2007,
244(
3):
708-
717.
.
[179]
SkaaneP, SebuødegårdS, BandosAI, et al.
Performance of breast cancer screening using digital breast tomosynthesis: results from the prospective population-based Oslo tomosynthesis screening trial[J].
Breast Cancer Res Treat,
2018,
169(
3):
489-
496.
.
[180]
SkaaneP, SkjennaldA, YoungK, et al.
Follow-up and final results of the Oslo Ⅰ study comparing screen-film mammography and full-field digital mammography with soft-copy reading[J].
Acta Radiol,
2005,
46(
7):
679-
689.
.
[181]
SungJS, LebronL, KeatingD, et al.
Performance of dual-energy contrast-enhanced digital mammography for screening women at increased risk of breast cancer[J].
Radiology,
2019,
293(
1):
81-
88.
.
[182]
TaplinSH, AbrahamL, GellerBM, et al.
Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography[J].
J Natl Cancer Inst,
2010,
102(
14):
1040-
1051.
.
[183]
TennantSL, JamesJJ, CornfordEJ, et al.
Contrast-enhanced spectral mammography improves diagnostic accuracy in the symptomatic setting[J].
Clin Radiol,
2016,
71(
11):
1148-
1155.
.
[184]
ThurfjellEL, HolmbergLH, PerssonIR.
Screening mammography: sensitivity and specificity in relation to hormone replacement therapy[J].
Radiology,
1997,
203(
2):
339-
341.
.
[185]
ThurfjellMG, VitakB, AzavedoE, et al.
Effect on sensitivity and specificity of mammography screening with or without comparison of old mammograms[J].
Acta Radiol,
2000,
41(
1):
52-
56.
[186]
TolmosJ, CutroneJA, WangB, et al.
Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography[J].
J Natl Cancer Inst,
1998,
90(
11):
846-
849.
.
[187]
TsurudaKM, SagstadS, SebuødegårdS, et al.
Validity and reliability of self-reported health indicators among women attending organized mammographic screening[J].
Scand J Public Health,
2018,
46(
7):
744-
751.
.
[188]
van Breest SmallenburgV, DuijmLE, VoogdAC, et al.
Lower sensitivity of screening mammography after previous benign breast surgery[J].
Int J Cancer,
2012,
130(
1):
122-
128.
.
[189]
Van LandeghemP, BleyenL, De BackerG.
Age-specific accuracy of initial versus subsequent mammography screening: results from the Ghent breast cancer-screening programme[J].
Eur J Cancer Prev,
2002,
11(
2):
147-
151.
.
[190]
VenturiniE, LosioC, PanizzaP, et al.
Tailored breast cancer screening program with microdose mammography, us, and mr imaging : Short-term results of a pilot study in 40-49-year-old wome[J].
Radiology,
2013,
268(
2):
347-
355.
.
[191]
WandersJO, HollandK, VeldhuisWB, et al.
Volumetric breast density affects performance of digital screening mammography[J].
Breast Cancer Res Treat,
2017,
162(
1):
95-
103.
.
[192]
YankaskasBC, HaneuseS, KappJM, et al.
Performance of first mammography examination in women younger than 40 years[J].
J Natl Cancer Inst,
2010,
102(
10):
692-
701.
.
[193]
YankaskasBC, MayRC, MatuszewskiJ, et al.
Effect of observing change from comparison mammograms on performance of screening mammography in a large community-based population[J].
Radiology,
2011,
261(
3):
762-
770.
.
[194]
YankaskasBC, SchellMJ, BirdRE, et al.
Reassessment of breast cancers missed during routine screening mammography: a community-based study[J].
AJR Am J Roentgenol,
2001,
177(
3):
535-
541.
.
[195]
ZackrissonS, LångK, RossoA, et al.
One-view breast tomosynthesis versus two-view mammography in the Malmö breast tomosynthesis screening trial (MBTST): A prospective, population-based, diagnostic accuracy study[J].
Lancet Oncol,
2018,
19(
11):
1493-
1503.
.
[196]
陈鹏.
乳腺彩超和乳腺钼靶筛查乳腺癌的价值研究[J].
中国卫生工程学，
2017,
16(
4)：
508-509, 511.
ChenP.
Study on the value of mammography and molybdenum target in screening breast cancer[J].
Chin J Public Heal Engineering,
2017,
16(
4):
508-509, 511.
[197]
丁雪梅，王炳良.
年龄和肿块大小对超声和钼靶X线在乳腺癌筛查及检查中的影响[J].
当代医学，
2017,
23(
24)：
9-
11.
.
DingXM, WangBL.
Effects of age and mass size on ultrasound and molybdenum target X in breast cancer screening and screening[J].
Contemp Med,
2017,
23(
24):
9-
11.
.
[198]
樊哲，陈雯婷，滕元，等.
探讨中国南方流动妇女乳腺癌筛查最优模式[J].
中国妇幼健康研究，
2019,
30(
6)：
681-
686.
.
FanZ, ChenWT, TengY, et al.
Exploring the best model of breast cancer screening for migrant women in Southern China[J].
Chin J Woman and Child Heal Res,
2019,
30(
6):
681-
686.
.
[199]
胡翠群.
乳腺钼钯联合超声检查在早期乳腺癌筛查中的诊断价值分析[J].
实用医技杂志，
2017,
24(
5)：
502-
504.
.
HuCQ.
Analysis of diagnostic value of molybdenum target combined with ultrasound in early breast cancer screening[J].
J Pract Med Techniques,
2017,
24(
5):
502-
504.
.
[200]
匡晓梅，王莹，肖琳，等.
中山市35～59岁妇女免费乳腺癌普查模式及结果分析[J].
实用预防医学，
2014,
21(
2)：
149-
152.
.
KuangXM, WangY, XiaoL, et al.
Analysis of free screening model and result of breast cancer in women aged 35-59 years in Zhongshan City[J].
J pract prev med,
2014,
21(
2):
149-
152.
.
[201]
李国栋，李光民，李素荣.
数字乳腺断层摄影技术在女性乳腺癌筛查中的价值[J].
中国辐射卫生，
2014,
23(
6)：
565-
566.
LiGD, LiGM, LiSR.
Value of digital mammography in female breast cancer screening[J].
Chin J Radio Heal,
2014,
23(
6):
565-
566.
[202]
李莉，刘巍，汪湍，等.
不同筛查方案在新疆维族女性乳腺癌筛查中的准确性及临床意义[J/CD].
中国医学前沿杂志：电子版，
2015, (
5)：
42-
45.
.
LiL, LiuW, WangT, et al.
The accuracy and clinical significance of different screening methods for breast cancer among Xinjiang Uigur women[J/CD].
Chin J Frontiers of Med Science(Electronic Version),
2015, (
5):
42-
45.
.
[203]
李蔓，韩历丽，高倩.
临床体检、超声与钼靶X线检查在乳腺癌筛查中的应用[J].
中国生育健康杂志，
2014, (
3)：
202-
206.
LiM, HanLL, GaoQ.
Clinical examination, ultrasound and molybdenum target X line examination in breast cancer screening[J].
Chin J Reproductive Heal,
2014, (
3):
202-
206.
[204]
李晓波.
女性乳腺癌筛查首轮影像结果分析[J].
中国保健营养，
2016,
26(
30)：
382-
382.
.
LiXB.
Analysis of the results of the first image of female breast cancer screening[J].
Heal Nutrition in China,
2016,
26(
30):
382-
382.
.
[205]
李兴慧，许广照，王健，等.
彩超联合钼靶在乳腺筛查中的价值[J].
中国肿瘤，
2013,
22(
03)：
207-
210.
.
LiXH, XuGZ, WangJ, et al.
The value of color doppler ultrasound combined with molybdenum target in the screening for breast diseases[J].
China Cancer,
2013,
22(
03):
207-
210.
.
[206]
林弋轩，夏江燕，何秀超，等.
超声联合(并联)钼靶X线在乳腺癌筛查中的诊断价值研究[J].
中国社区医师，
2016,
32(
36)：
127-
128.
.
LinYX, XiaJY, HeXC, et al.
Study on the diagnostic value of ultrasound combined with mammography in the screening of breast cancer[J].
Chin Community Doctors,
2016,
32(
36):
127-
128.
.
[207]
马恒敏，王圣芳，冷玲，等.
山东省肥城市2008-2011年乳腺癌筛查结果分析[J].
中华肿瘤防治杂志，
2013,
20(
2)：
88-
92.
MaHM, WangSF, LengL, et al.
Screening for breast cancer in Feicheng, Shandong Province, 2008-2011[J].
Chin J Cancer Prev Treat,
2013,
20(
2):
88-
92.
[208]
欧艳红，彭飞蝶，李金梅，等.
农村妇女乳腺癌筛查方法的探讨[J].
实用预防医学，
2016,
23(
2)：
196-
198.
.
OuYH, PengFD, LiJM, et al.
Methods of screening breast cancer among rural women[J].
J Pract Prev Med,
2016,
23(
2):
196-
198.
.
[209]
荣磊，李欢，王恩礼.
X线及超声在深圳市女性乳腺癌筛查中的应用研究[J].
中国妇幼保健，
2016,
31(
4)：
881-
883.
.
RongL, LiH, WangEL.
Application of X ray and ultrasound in screening breast cancer in Shenzhen[J].
Maternal and Child Health Care of China,
2016,
31(
4):
881-
883.
.
[210]
王翔.
乳腺钼靶检查在早期乳腺癌筛查中的价值分析[J].
影像研究与医学应用，
2019,
3(
10)：
171-
172.
WangX.
Value analysis of mammography in early breast cancer screening[J].
J Imag Res and Med Applications,
2019,
3(
10):
171-
172.
[211]
杨威，唐世早，芮兵.
乳腺钼靶摄片在早期乳腺癌筛查中的临床价值分析[J].
当代医学，
2015,
21(
18)：
106.
.
YangW, TangSZ, RuiB.
Clinical value of mammography in early breast cancer screening[J].
Contemp Med,
2015,
21(
18):
106.
.
[212]
杨振华，戴宏季，闫烨，等.
不同钼靶X线阳性标准对乳腺癌筛查成本效果的影响[J].
中国肿瘤临床，
2012,
39(
6)：
328-330，339.
.
YangZH, DaiHJ, YanY, et al.
Effect of mammography-positive criteria on the cost-effectiveness of breast cancer screening[J].
Chin J Clin Oncol,
2012,
39(
6):
328-330, 339.
.
[213]
张礼群.
乳腺钼靶普查在乳腺癌筛查中的应用价值[J].
影像研究与医学应用，
2019,
3(
21)：
136-
137.
ZhangLQ.
Application value of mammography screening in breast cancer screening[J].
J Imag Res and Med Applications,
2019,
3(
21):
136-
137.
[214]
郑华英，罗志宏，黄嫦静，等.
乳腺钼靶与高频彩超相结合对粤北山区乳腺癌筛查的探讨[J].
医药前沿，
2012,
2(
19)：
46-
48.
.
ZhengHY, LuoZH, HuangCJ, et al.
Study on breast cancer screening in Northern Guangdong Mountain by combination of molybdenum target and high frequency color ultrasound[J].
Pharmaceutical Frontier,
2012,
2(
19):
46-
48.
.
[215]
周世崇，范亦武，曾炜，等.
上海社区乳腺癌筛查初步小结：超声及乳腺X线的漏诊、误诊病例分析[J].
上海医学影像，
2012,
21(
4)：
291-
293.
.
ZhouSC, FanYW, ZengW, et al.
The first stage conclusion of breast cancer screening in Shanghai community: missed and misdiagnostic cases analysis of mammography and ultrasonography[J].
Oncoradiology,
2012,
21(
4):
291-
293.
.
[216]
PhiXA, HoussamiN, HooningMJ, et al.
Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis[J].
Eur J Cancer,
2017,
85:
31-
38.
.
[217]
AnP, ZhongS, ZhangR, et al.
A Cross-sectional observational study to compare the role of ultrasound with mammography in women identified at high risk for breast cancer in a population in China[J].
Med Sci Monit,
2020,
26:
e919777.
.
[218]
BergWA, BandosAI, MendelsonEB, et al.
Ultrasound as the primary screening test for breast cancer: Analysis from acrin 6666[J].
J Natl Cancer Inst,
2015,
108(
4):
djv367.
.
[219]
BergWA, BlumeJD, CormackJB, et al.
Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer[J].
JAMA,
2008,
299(
18):
2151-
2163.
.
[220]
ChoiWJ, ChaJH, KimHH, et al.
Comparison of automated breast volume scanning and hand-held ultrasound in the detection of breast cancer: an analysis of 5, 566 patient evaluations[J].
Asian Pac J Cancer Prev,
2014,
15(
21):
9101-
9105.
.
[221]
CortesiL, CanossiB, BattistaR, et al.
Breast ultrasonography (BU) in the screening protocol for women at hereditary-familial risk of breast cancer: has the time come to rethink the role of BU according to different risk categories？[J].
Int J Cancer,
2019,
144(
5):
1001-
1009.
.
[222]
KellyKM, DeanJ, ComuladaWS, et al.
Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts[J].
Eur Radiol,
2010,
20(
3):
734-
742.
.
[223]
KuhlCK, SchmutzlerRK, LeutnerCC, et al.
Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results[J].
Radiology,
2000,
215(
1):
267-
279.
.
[224]
KuhlCK, SchradingS, LeutnerCC, et al.
Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer[J].
J Clin Oncol,
2005,
23(
33):
8469-
8476.
.
[225]
PhalakKA, MiltonDR, YangWT, et al.
Supplemental ultrasound screening in patients with a history of lobular neoplasia[J].
Breast J,
2019,
25(
2):
250-
256.
.
[226]
ShenS, ZhouY, XuY, et al.
A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women[J].
Br J Cancer,
2015,
112(
6):
998-
1004.
.
[227]
SimLS, HendriksJH, Fook-ChongSM.
Breast ultrasound in women with familial risk of breast cancer[J].
Ann Acad Med Singap,
2004,
33(
5):
600-
606.
[228]
TagliaficoAS, MariscottiG, ValdoraF, et al.
A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2)[J].
Eur J Cancer,
2018,
104:
39-
46.
.
[229]
WarnerE, PlewesDB, HillKA, et al.
Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination[J].
JAMA,
2004,
292(
11):
1317-
1325.
.
[230]
WarnerE, PlewesDB, ShumakRS, et al.
Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer[J].
J Clin Oncol,
2001,
19(
15):
3524-
3531.
.
[231]
WeinsteinSP, LocalioAR, ConantEF, et al.
Multimodality screening of high-risk women: a prospective cohort study[J].
J Clin Oncol,
2009,
27(
36):
6124-
6128.
.
[232]
WilczekB, WilczekHE, RasouliyanL, et al.
Adding 3D automated breast ultrasound to mammography screening in women with heterogeneously and extremely dense breasts: Report from a hospital-based, high-volume, single-center breast cancer screening program[J].
Eur J Radiol,
2016,
85(
9):
1554-
1563.
.
[233]
林邦义，陈金春，黄天舒，等.
瑞安市城乡妇女乳腺癌超声和X线钼靶摄影筛查及综合防治研究[J].
现代实用医学，
2014,
26(
5)：
541-542, 545.
.
LinBY, ChenJC, HuangTS, et al.
Ultrasound and X molybdenum target screening and comprehensive prevention and control of breast cancer in urban and rural women of Rui′an City[J].
Modern Practical Medicine,
2014,
26(
5):
541-542, 545.
.
[234]
吴东辉，翟志华.
磁共振与乳腺X片早期筛查对乳腺癌女性患者预后的差异比较分析[J].
影像研究与医学应用，
2019,
3(
23)：
249-
250.
WuDH, ZhaiZH.
Comparative analysis of prognosis of women with breast cancer by early screening with magnetic resonance and breast X ray[J].
J Imag Res and Med Applications,
2019,
3(
23):
249-
250.
[235]
许娟，王颀，马宏民，等.
体检联合超声补充X射线钼靶检查乳腺癌筛查模式初步应用评价[J].
中华肿瘤防治杂志，
2013,
20(
17)：
1295-
1299.
.
XuJ, WangY, MaHM, et al.
Primary efficacy of physical examination combined with ultragraphy and complemented with mammography for breast cancer screening[J].
Chin J Cancer Prev Treat,
2013,
20(
17):
1295-
1299.
.
[236]
邹兴文，杨丽，李伟栋.
广州市173335名农村妇女乳腺癌筛查分析[J].
中国肿瘤，
2018,
27(
8)：
568-
572.
.
ZouXW, YangL, LiWD.
Analysis of breast cancer screening among 173 335 women from rural areas in Guangzhou[J].
China Cancer,
2018,
27(
8):
568-
572.
.
[237]
BrancatoB, BonardiR, CatarziS, et al.
Negligible advantages and excess costs of routine addition of breast ultrasonography to mammography in dense breasts[J].
Tumori,
2007,
93(
6):
562-
566.
[238]
BremRF, TabárL, DuffySW, et al.
Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: the somoinsight study[J].
Radiology,
2015,
274(
3):
663-
673.
.
[239]
BuchbergerW, Geiger-GritschS, KnappR, et al.
Combined screening with mammography and ultrasound in a population-based screening program[J].
Eur J Radiol,
2018,
101:
24-
29.
.
[240]
CorsettiV, HoussamiN, GhirardiM, et al.
Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up[J].
Eur J Cancer,
2011,
47(
7):
1021-
1026.
.
[241]
GiulianoV, GiulianoC.
Improved breast cancer detection in asymptomatic women using 3D-automated breast ultrasound in mammographically dense breasts[J].
Clin Imaging,
2013,
37(
3):
480-
486.
.
[242]
HooleyRJ, GreenbergKL, StackhouseRM, et al.
Screening US in patients with mammographically dense breasts: Initial experience with connecticut public act 09-41[J].
Radiology,
2012,
265(
1):
59-
69.
.
[243]
KimSY, ChoN, KimSY, et al.
Supplemental breast US screening in women with a personal history of breast cancer: A matched cohort study[J].
Radiology,
2020,
295(
1):
54-
63.
.
[244]
LeeSH, YiA, JangMJ, et al.
Supplemental screening breast us in women with negative mammographic findings: effect of routine axillary scanning[J].
Radiology,
2018,
286(
3):
830-
837.
.
[245]
LeongLCH, GognaA, PantR, et al.
Supplementary breast ultrasound screening in Asian women with negative but dense mammograms-a pilot study[J].
Ann Acad Med Singap,
2012,
41(
10):
432-
439.
[246]
MoonHJ, JungI, ParkSJ, et al.
Comparison of cancer yields and diagnostic performance of screening mammography vs. supplemental screening ultrasound in 4394 women with average risk for breast cancer[J].
Ultraschall Med,
2015,
36(
3):
255-
263.
.
[247]
ParrisT, WakefieldD, FrimmerH.
Real world performance of screening breast ultrasound following enactment of connecticut bill 458[J].
Breast J,
2013,
19(
1):
64-
70.
.
[248]
TagliaficoAS, CalabreseM, MariscottiG, et al.
Adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts: Interim report of a prospective comparative trial[J].
J Clin Oncol,
2016,
34(
16):
1882-
1888.
.
[249]
TutarB, Esen IctenG, GuldoganN, et al.
Comparison of automated versus hand-held breast US in supplemental screening in asymptomatic women with dense breasts: is there a difference regarding woman preference, lesion detection and lesion characterization？[J].
Arch Gynecol Obstet,
2020,
301(
5):
1257-
1265.
.
[250]
WeigertJ, SteenbergenS.
The connecticut experiment: the role of ultrasound in the screening of women with dense breasts[J].
Breast J,
2012,
18(
6):
517-
522.
.
[251]
WeigertJ, SteenbergenS.
The Connecticut experiments second year: Ultrasound in the screening of women with dense breasts[J].
Breast J,
2015,
21(
2):
175-
180.
.
[252]
YoukJH, KimEK, KimMJ, et al.
Performance of hand-held whole-breast ultrasound based on BI-RADS in women with mammographically negative dense breast[J].
Eur Radiol,
2011,
21(
4):
667-
675.
.
[253]
BergWA, ZhangZ, LehrerD, et al.
Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk[J].
JAMA,
2012,
307(
13):
1394-
1404.
.
[254]
KimSY, KimMJ, MoonHJ, et al.
Application of the downgrade criteria to supplemental screening ultrasound for women with negative mammography but dense breasts[J].
Medicine,
2016,
95(
44):
e5279.
.
[255]
KolbTM, LichyJ, NewhouseJH.
Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27, 825 patient evaluations[J].
Radiology,
2002,
225(
1):
165-
175.
.
[256]
YounI, YoonJH, YoukJH, et al.
Necessity of axillary scanning after negative finding on both mammography and subsequent breast ultrasound[J].
Ultrasound Med Biol,
2018,
44(
1):
71-
77.
.
[257]
封任冬，汪华，丁莹莹，等.
乳腺癌筛查模式的探讨[J].
临床放射学杂志，
2016,
35(
1)：
36-
40.
FengRD, WangH, DingYY, et al.
To investigate the screening model of breast cancer[J].
J Clin Radiol,
2016,
35(
1):
36-
40.
[258]
ChiarelliAM, BlackmoreKM, MuradaliD, et al.
Performance measures of magnetic resonance imaging plus mammography in the high risk Ontario breast screening program[J].
J Natl Cancer Inst,
2020,
112(
2):
136-
144.
.
[259]
HagenAI, KvistadKA, MaehleL, et al.
Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series[J].
Breast,
2007,
16(
4):
367-
374.
.
[260]
KriegeM, BrekelmansCT, ObdeijnIM, et al.
Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer[J].
Breast Cancer Res Treat,
2006,
100(
1):
109-
119.
.
[261]
LeachMO, BoggisCR, DixonAK, et al.
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)[J].
Lancet,
2005,
365(
9473):
1769-
1778.
.
[262]
LehmanCD, BlumeJD, WeatherallP, et al.
Screening women at high risk for breast cancer with mammography and magnetic resonance imaging[J].
Cancer,
2005,
103(
9):
1898-
1905.
.
[263]
MorrisEA, LibermanL, BallonDJ, et al.
MRI of occult breast carcinoma in a high-risk population[J].
AJR Am J Roentgenol,
2003,
181(
3):
619-
626.
.
[264]
PassaperumaK, WarnerE, CauserPA, et al.
Long-term results of screening with magnetic resonance imaging in women with BRCA mutations[J].
Br J Cancer,
2012,
107(
1):
24-
30.
.
[265]
PodoF, SardanelliF, CaneseR, et al.
The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk[J].
J Exp Clin Cancer Res,
2002,
21(
Suppl 3):
115-
124.
[266]
RiedlCC, LuftN, BernhartC, et al.
Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density[J].
J Clin Oncol,
2015,
33(
10):
1128-
1135.
.
[267]
RiedlCC, PonholdL, FloryD, et al.
Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer[J].
Clin Cancer Res,
2007,
13(
20):
6144-
6152.
.
[268]
RijnsburgerAJ, ObdeijnIM, KaasR, et al.
BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study[J].
J Clin Oncol,
2010,
28(
36):
5265-
5273.
.
[269]
SaadatmandS, GeuzingeHA, RutgersEJT, et al.
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial[J].
Lancet Oncol,
2019,
20(
8):
1136-
1147.
.
[270]
SardanelliF, PodoF, D′AgnoloG, et al.
Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results[J].
Radiology,
2007,
242(
3):
698-
715.
.
[271]
SardanelliF, PodoF, SantoroF, et al.
Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results[J].
Invest Radiol,
2011,
46(
2):
94-
105.
.
[272]
StoutjesdijkMJ, BoetesC, JagerGJ, et al.
Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer[J].
J Natl Cancer Inst,
2001,
93(
14):
1095-
1102.
.
[273]
Tilanus-LinthorstMM, BartelsCC, ObdeijnAI, et al.
Earlier detection of breast cancer by surveillance of women at familial risk[J].
Eur J Cancer,
2000,
36(
4):
514-
519.
.
[274]
TropI, LalondeL, MayrandMH, et al.
Multimodality breast cancer screening in women with a familial or genetic predisposition[J].
Curr Oncol,
2010,
17(
3):
28-
36.
.
[275]
van ZelstJCM, MusRDM, WoldringhG, et al.
Surveillance of women with the BRCA1 or BRCA2 mutation by using biannual automated breast US, MR imaging, and mammography[J].
Radiology,
2017,
285(
2):
376-
388.
.
[276]
PickA, BerryS, GilbertK, et al.
Informed consent in clinical research[J].
Nurs stand,
2013,
27(
49):
44-
47.
.
[277]
中华预防医学会.
大型人群队列研究数据安全技术规范(T/CPMA 002-2018)[J].
中华流行病学杂志，
2019,
40(
1)：
12-
16.
.
Chinese Preventive Medicine Association.
Technical specification of data security for large population-based cohort study(T/CPMA 002-2018)[J].
Chin J Epidemiol,
2019,
40(
1):
12-
16.
.
 - 中华肿瘤杂志_files/jihe2.png)
 - 中华肿瘤杂志_files/weixin.gif)
 - 中华肿瘤杂志_files/sinaminiblog.gif)
 - 中华肿瘤杂志_files/youdaonote.gif)
 - 中华肿瘤杂志_files/twitter.gif)
 - 中华肿瘤杂志_files/facebook.gif)
 - 中华肿瘤杂志_files/gplus.gif)
 - 中华肿瘤杂志_files/evernote.gif)
 - 中华肿瘤杂志_files/reddit.gif)
 - 中华肿瘤杂志_files/diigo.gif)
 - 中华肿瘤杂志_files/linkedin.gif)
 - 中华肿瘤杂志_files/instapaper.gif)
 - 中华肿瘤杂志_files/itieba.gif)
 - 中华肿瘤杂志_files/friendfeed.gif)
 - 中华肿瘤杂志_files/douban.gif)
 - 中华肿瘤杂志_files/clipboard.gif)
 - 中华肿瘤杂志_files/favorite.gif)
 - 中华肿瘤杂志_files/gmail.gif)
 - 中华肿瘤杂志_files/poco.gif)
 - 中华肿瘤杂志_files/readitlater.gif)